JP2024541319A5 - - Google Patents
Info
- Publication number
- JP2024541319A5 JP2024541319A5 JP2024527354A JP2024527354A JP2024541319A5 JP 2024541319 A5 JP2024541319 A5 JP 2024541319A5 JP 2024527354 A JP2024527354 A JP 2024527354A JP 2024527354 A JP2024527354 A JP 2024527354A JP 2024541319 A5 JP2024541319 A5 JP 2024541319A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163277405P | 2021-11-09 | 2021-11-09 | |
| US63/277,405 | 2021-11-09 | ||
| US202163277767P | 2021-11-10 | 2021-11-10 | |
| US63/277,767 | 2021-11-10 | ||
| PCT/US2022/049318 WO2023086342A2 (en) | 2021-11-09 | 2022-11-08 | Opa1 antisense oligomers for treatment of conditions and diseases |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024541319A JP2024541319A (ja) | 2024-11-08 |
| JP2024541319A5 true JP2024541319A5 (https=) | 2026-02-03 |
| JPWO2023086342A5 JPWO2023086342A5 (https=) | 2026-02-03 |
Family
ID=86336660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527354A Pending JP2024541319A (ja) | 2021-11-09 | 2022-11-08 | 病態及び疾患の処置のためのｏｐａ１アンチセンスオリゴマー |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250059535A1 (https=) |
| EP (1) | EP4429714A2 (https=) |
| JP (1) | JP2024541319A (https=) |
| WO (1) | WO2023086342A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112022022889A2 (pt) | 2020-05-11 | 2023-04-04 | Stoke Therapeutics Inc | Oligômeros antissentido de opa1 para tratamento de condições e doenças |
| IT202200016884A1 (it) * | 2022-08-05 | 2024-02-05 | Univ Degli Studi Di Trento | Modifica di genomi della sequenza di Kozak per curare malattie |
| WO2025184574A1 (en) * | 2024-03-01 | 2025-09-04 | Stoke Therapeutics, Inc. | Treatment of eye diseases and diagnostics |
| WO2025240992A1 (en) * | 2024-05-24 | 2025-11-27 | PYC Therapeutics Limited | Agents for treatment of conditions associated with optic atrophy 1 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016081885A2 (en) * | 2014-11-20 | 2016-05-26 | Massachusetts Eye And Ear Infirmary | Panel-based genetic diagnostic testing for inherited eye diseases |
| GB2610100B (en) * | 2017-10-23 | 2023-08-16 | Stoke Therapeutics Inc | Antisense oligomers for treatment of non-sense mediated RNA decay based conditions and diseases |
| CN111518898B (zh) * | 2019-02-01 | 2022-07-26 | 中国科学院广州生物医药与健康研究院 | Opa1异形体蛋白在调控肝癌细胞增殖能力中的用途 |
-
2022
- 2022-11-08 WO PCT/US2022/049318 patent/WO2023086342A2/en not_active Ceased
- 2022-11-08 JP JP2024527354A patent/JP2024541319A/ja active Pending
- 2022-11-08 EP EP22893527.6A patent/EP4429714A2/en active Pending
-
2024
- 2024-05-08 US US18/658,390 patent/US20250059535A1/en active Pending